BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

The Latest News from BioAgilytix

Marc Westermann
4 January, 2021

BioAgilytix Welcomes Marc Westermann as Vice President of Business Development Europe to its Commercial Leadership Team

Durham, NC – BioAgilytix Labs is pleased to announce the appointment of Marc Westermann to its commercial leadership team as Vice President of Business Development Europe. Westermann brings more than…

Read More

Thermo Fisher Phadia 200
30 October, 2020

BioAgilytix Bioanalytical Lab Welcomes the Phadia 200 to Its Hamburg Laboratory

HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments. With the help of this innovative instrument,…

Read More

The Great Seal of the State of North Carolina
29 October, 2020

Governor Cooper Announces 878 New Jobs as BioAgilytix Chooses Durham for Major Expansion

Bioanalytical life science company to invest $61.5 million RALEIGH: BioAgilytix Labs, LLC, a leading life science testing company, will create 878 jobs and invest $61.5 million in Durham, Governor Roy…

Read More

Kennon Broadhurst
22 September, 2020

BioAgilytix Welcomes Kennon Broadhurst as Vice President of Global Marketing to Its Commercial Leadership Team

September 22, 2020-Durham, NC-BioAgilytix Labs is pleased to announce the appointment of Kennon Broadhurst to its Commercial Leadership team as Vice President of Global Marketing. Kennon joins BioAgilytix after having…

Read More

24 August, 2020

BioAgilytix’s Durham, North Carolina Laboratory Receives Certificate of Accreditation from COLA

BioAgilytix has received its Certificate of Accreditation for high complexity testing in the diagnostic immunology specialty from the Commission on Office Laboratory Accreditation (COLA) for its U.S. facility in Durham, North Carolina.

Read More

19 August, 2020

BioAgilytix Welcomes Marianne Scheel Fjording, Ph.D. to Team as Scientific Officer

Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.

Read More

17 August, 2020

BioAgilytix Labs Launches COVIDence™ Program for COVID-19 Workforce Testing

The end-to-end service handles all aspects of sample collection logistics, testing, and results reporting for employers, providing an easy-to-implement solution to effectively mitigate COVID-19 exposure within their workforces.

Read More

BioAgilytix Diagnostics Logo against a black background
3 August, 2020

BioAgilytix Rebrands Its Cambridge Biomedical Diagnostic Testing Division to BioAgilytix Diagnostics

The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.

Read More

BioAgilytix leadership - Dr. Chad Briscoe
30 June, 2020

Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Read More